Protalix Biotherapeutics Inc (PLX)

Cash & Short-Term Investments

$40.66M

Quarterly · Period ending: · USD

PLX logo

PLX Cash & Short-Term Investments

Latest reported$40.66M
PLX Quarterly Cash & Short-Term Investments ($700.00K → $40.66M)
High-resolution chart · PNG

PLX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
40,656,000
51,794,000
30,273,000
29,370,000
33,398,000
34,743,000
34,830,000
27,409,000
45,029,000
48,487,000
44,560,000
40,975,000
48,184,000
33,036,000
22,180,000
20,811,000
28,574,000
32,917,000
38,985,000
48,659,000
76,940,000
70,430,000
38,545,000
41,293,000
34,990,000
36,675,000
17,792,000
21,442,000
25,096,000
30,363,000
37,808,000
41,868,000
28,327,000
41,319,000
51,163,000
33,482,000
34,533,000
48,017,000
63,281,000
51,320,000
54,626,000
66,669,000
76,374,000
34,248,000
43,238,000
47,958,000
54,767,000
60,317,000
71,144,000
77,690,000
86,398,000
91,397,000
33,126,000
41,870,000
52,035,000
50,216,000
59,280,000
45,605,000
27,001,000
34,564,000
44,054,000
50,227,000
35,900,000
44,401,000
54,961,000
69,364,000
81,266,000
22,610,000
29,132,000
34,911,000
42,596,000
46,045,000
53,360,000
57,782,000
61,813,000
20,440,000
22,489,000
24,896,000
15,378,000
825,702
924,871
931,724
985,238
493,789
515,153
533,190
563,713
579,065
622,143
668,487
731,838
756,053
776,581
819,368
807,639
823,609
836,798
862,762
915,635
932,843
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.